세계의 혈관조영 장비 시장 규모, 점유율, 동향 분석 : 제품별, 기술별, 시술별, 용도별, 지역별, 부문별 예측(2025-2030년)

Angiography Equipment Market Size, Share & Trends Analysis Report By Product (Angiography Systems, Catheters), By Technology (X-Ray, MRA, CT), By Procedure, By Application, By Region, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,221,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,602,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,366,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

혈관조영 장비 시장의 성장과 동향 :

Grand View Research, Inc의 최신 리포트에 따르면 세계의 혈관조영 장비 시장 규모는 2030년까지 157억 달러에 달할 전망입니다.

이 시장은 고령 인구 증가, 심혈관 질환(CVD) 및 관련 위험인자 유병률 증가, 기술 발전, 헬스 테크 분야에 대한 투자로 인해 2025-2030년 연평균 6.1%의 급격한 성장이 예상됩니다. 세계보건기구(WHO)의 보고에 따르면 CVD는 미국, 영국 등의 국가에서 주요 사망 원인 중 하나입니다.

관상동맥질환(CAD)은 가장 흔한 형태의 CVD이며, 세계보건기구(WHO)는 세계 심장 구상을 통해 각국 정부가 고혈압 및 당뇨병과 같은 심혈관 위험요인을 관리할 수 있도록 지원하고 있습니다. 이러한 모든 요인들이 예측 기간 중 시장 확대를 촉진할 것으로 예상되며, CVD의 더 나은 시각화 및 평가를 제공하는 영상 진단 양식의 급속한 발전도 향후 수년간 혈관조영장비 시장을 촉진할 것으로 보입니다.

지역별로는 북미가 2018년 가장 큰 시장 점유율을 차지했으며, 예측 기간 중 그 지위를 유지할 것으로 예상됩니다. 브라질, 중국 등의 국가는 높은 품질 기준으로 인해 미국에서 의료기기를 수출하고 있습니다. 일본, 중국 등 개발도상국의 양호한 정부 규제로 인해 아시아태평양은 예측 기간 중 건전한 CAGR로 확대될 것으로 예상됩니다. 예를 들어 일본에서는 현지 제조업체가 첨단 혈관조영 진단 장비를 제공하도록 장려하는 상환 정책을 시행하고 있습니다.

혈관조영장비 시장 : 분석 개요

• 혈관조영 시스템 부문은 지속적인 투자, 기술 발전, 적용 범위 확대로 인해 2024년 26.5%의 점유율로 시장을 선도했습니다.
• 관상동맥 조영술 분야는 2024년 45.8%의 점유율로 시장을 장악했습니다.
• 시술별로 보면 시장은 관상동맥, 혈관내, 신경혈관으로 구분됩니다. 영상 기술의 끊임없는 발전으로 질병의 더 나은 진단이 가능해졌습니다.
• 2024년에는 엑스레이 부문이 36.2%로 가장 큰 점유율을 차지했습니다. 기술에 따라 시장은 엑스레이, MRA, CT로 구분됩니다.

목차

제1장 분석 방법·범위

제2장 개요

제3장 혈관조영 장비 시장 : 변동 요인·경향·범위

• 시장 연관 전망
  • 모시장 전망
  • 관련/부수 시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 혈관조영 장비 시장 : 분석 툴
  • 업계 분석 : Porter의 산업 분석
  • PESTEL 분석

제4장 혈관조영 장비 시장 : 제품별 추정·동향 분석

• 세계의 혈관조영 장비 시장 : 제품별 대시보드
• 세계의 혈관조영 장비 시장 : 제품별 변동 분석
• 세계의 혈관조영 장비 시장 : 제품별(매출 기반)
• 혈관조영 시스템
• 카테터
• 가이드와이어
• 풍선
• 조영제
• 혈관 폐쇄 기기
• 혈관조영용 액세서리

제5장 혈관조영 장비 시장 : 기술별 추정·동향 분석

• 세계의 혈관조영 장비 시장 : 기술별 대시보드
• 세계의 혈관조영 장비 시장 : 기술별 변동 분석
• 세계의 혈관조영 장비 시장 : 기술별(매출 기반)
• X선
• MRA
• CT

제6장 혈관조영 장비 시장 : 시술별 추정·동향 분석

• 세계의 혈관조영 장비 시장 : 시술별 대시보드
• 세계의 혈관조영 장비 시장 : 시술별 변동 분석
• 세계의 혈관조영 장비 시장 : 시술별(매출 기반)
• 관상
• 혈관내
• 신경혈관

제7장 혈관조영 장비 시장 : 용도별 추정·동향 분석

• 세계의 혈관조영 장비 시장 : 용도별 대시보드
• 세계의 혈관조영 장비 시장 : 용도별 변동 분석
• 세계의 혈관조영 장비 시장 : 용도별(매출 기반)
• 진단
• 치료

제8장 혈관조영 장비 시장 : 지역별 추정·동향 분석(국가별·제품별·기술별·시술별·용도별)

• 지역 대시보드
• 시장 규모 예측과 동향 분석(2018-2030년)
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 노르웨이
  • 스웨덴
  • 덴마크
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 태국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트
  • 쿠웨이트

제9장 경쟁 구도

• 최신 동향과 영향 분석 : 주요 시장 참여 기업별
• 기업/경쟁의 분류
• 벤더 구도
  • 주요 유통업체·채널 파트너 리스트
  • 주요 고객
  • 주요 기업의 시장 점유율의 분석(2024년)
• 기업 개요
  • Medtronic plc
  • Boston Scientific Corporation
  • Angiodynamics, Inc
  • Abbott
  • MicroPort Scientific Corporation
  • B. BRAUN SE
  • KONINKLIJKE PHILIPS NV
  • GE Healthcare
  • Cardinal Health
  • SIEMENS HEALTHINEERS AG
  • SHIMADZU CORPORATION

KSA

영문 목차

영문목차

Angiography Equipment Market Growth & Trends:

The global angiography equipment market size is expected to reach USD 15.7 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to witness an exponential CAGR of 6.1% from 2025 to 2030 due to growing geriatric population, increasing prevalence of Cardiovascular Diseases (CVDs) with associated risk factors, technological advancements, and investments in the health tech sector. According to the World Health Organization (WHO) report, CVD is one of the leading causes of death in countries, such as U.S. and U.K.

Coronary Artery Disease (CAD) is the most prevalent form of CVD. Through Global Hearts Initiative, the WHO is supporting governments in controlling cardiovascular risk factors, such as hypertension and diabetes. All these factors are projected to boost the market expansion over the forecast period. Rapid development of the diagnostic imaging modalities providing better visualization and assessment of CVD is also likely to drive the angiography devices market in the years to come.

Geographically, North America held the largest market share in 2018 and is expected to maintain its position during the forecast period. Countries, such as Brazil and China, export the medical devices from U.S. owing to the high standard of quality. Due to favorable government regulations in developing countries, such as Japan and China, the Asia Pacific region is projected to expand at a healthy CAGR during the estimated period. For instance, reimbursement policy in Japan encourages the local manufacturers to provide advanced angiography diagnostic devices.

Angiography Equipment Market Report Highlights:

• The angiography systems segment led the market with a share of 26.5% in 2024 due to continuous investments, technological advancements, and growing scope of applications
• The coronary angiography segment dominated the market with a share of 45.8% in 2024
• In terms of procedure, the market is segmented into coronary, endovascular, and neurovascular. Constant developments in imaging technology have enabled better diagnosis of the disease
• The X-ray segment held the largest share of 36.2% in 2024. Based on technology, the market is segmented into X-ray, MRA, and CT

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Technology
  • 1.2.3. Procedure
  • 1.2.4. Application
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Volume price analysis (Model 2)
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Technology outlook
  • 2.2.3. Procedure outlook
  • 2.2.4. Application outlook
• 2.3. Competitive Insights

Chapter 3. Angiography Equipment Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing prevalence of cardiovascular diseases
    • 3.2.1.2. Technological advancements
    • 3.2.1.3. Aging population
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High cost of equipment
    • 3.2.2.2. Regulatory complexities
• 3.3. Angiography Equipment Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Angiography Equipment Market: Product Estimates & Trend Analysis

• 4.1. Global Angiography Equipment Market: Product Dashboard
• 4.2. Global Angiography Equipment Market: Product Movement Analysis
• 4.3. Global Angiography Equipment Market by Product, Revenue
• 4.4. Angiography Systems
  • 4.4.1. Angiography systems market estimates and forecasts 2018 to 2030 (USD Billion)
• 4.5. Catheters
  • 4.5.1. Catheters market estimates and forecasts 2018 to 2030 (USD Billion)
• 4.6. Guidewire
  • 4.6.1. Guidewire market estimates and forecasts 2018 to 2030 (USD Billion)
• 4.7. Balloons
  • 4.7.1. Balloons market estimates and forecasts 2018 to 2030 (USD Billion)
• 4.8. Contrast Media
  • 4.8.1. Contrast media market estimates and forecasts 2018 to 2030 (USD Billion)
• 4.9. Vascular Closure Devices
  • 4.9.1. Vascular closure devices market estimates and forecasts 2018 to 2030 (USD Billion)
• 4.10. Angiography Accessories
  • 4.10.1. Angiography accessories market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 5. Angiography Equipment Market: Technology Estimates & Trend Analysis

• 5.1. Global Angiography Equipment Market: Technology Dashboard
• 5.2. Global Angiography Equipment Market: Technology Movement Analysis
• 5.3. Global Angiography Equipment Market by Technology Revenue
• 5.4. X-Ray
  • 5.4.1. X-Ray market estimates and forecasts 2018 to 2030 (USD Billion)
• 5.5. MRA
  • 5.5.1. MRA market estimates and forecasts 2018 to 2030 (USD Billion)
• 5.6. CT
  • 5.6.1. CT market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 6. Angiography Equipment Market: Procedure Estimates & Trend Analysis

• 6.1. Global Angiography Equipment Market: Procedure Dashboard
• 6.2. Global Angiography Equipment Market: Procedure Movement Analysis
• 6.3. Global Angiography Equipment Market by Procedure Revenue
• 6.4. Coronary
  • 6.4.1. Coronary market estimates and forecasts 2018 to 2030 (USD Billion)
• 6.5. Endovascular
  • 6.5.1. Endovascular market estimates and forecasts 2018 to 2030 (USD Billion)
• 6.6. Neurovascular
  • 6.6.1. Neurovascular market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 7. Angiography Equipment Market: Application Estimates & Trend Analysis

• 7.1. Global Angiography Equipment Market: Application Dashboard
• 7.2. Global Angiography Equipment Market: Application Movement Analysis
• 7.3. Global Angiography Equipment Market by Application, Revenue
• 7.4. Diagnostic
  • 7.4.1. Diagnostic market estimates and forecasts 2018 to 2030 (USD Billion)
• 7.5. Therapeutic
  • 7.5.1. Therapeutic market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 8. Angiography Equipment Market: Regional Estimates & Trend Analysis by Country, Product, Technology, Procedure and Application

• 8.1. Regional Dashboard
• 8.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 8.3. North America
  • 8.3.1. U.S.
    • 8.3.1.1. Key country dynamics
    • 8.3.1.2. Regulatory framework/ reimbursement structure
    • 8.3.1.3. Competitive scenario
    • 8.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.3.2. Canada
    • 8.3.2.1. Key country dynamics
    • 8.3.2.2. Regulatory framework/ reimbursement structure
    • 8.3.2.3. Competitive scenario
    • 8.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.3.3. Mexico
    • 8.3.3.1. Key country dynamics
    • 8.3.3.2. Regulatory framework/ reimbursement structure
    • 8.3.3.3. Competitive scenario
    • 8.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 8.4. Europe
  • 8.4.1. UK
    • 8.4.1.1. Key country dynamics
    • 8.4.1.2. Regulatory framework/ reimbursement structure
    • 8.4.1.3. Competitive scenario
    • 8.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.2. Germany
    • 8.4.2.1. Key country dynamics
    • 8.4.2.2. Regulatory framework/ reimbursement structure
    • 8.4.2.3. Competitive scenario
    • 8.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.3. France
    • 8.4.3.1. Key country dynamics
    • 8.4.3.2. Regulatory framework/ reimbursement structure
    • 8.4.3.3. Competitive scenario
    • 8.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.4. Italy
    • 8.4.4.1. Key country dynamics
    • 8.4.4.2. Regulatory framework/ reimbursement structure
    • 8.4.4.3. Competitive scenario
    • 8.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.5. Spain
    • 8.4.5.1. Key country dynamics
    • 8.4.5.2. Regulatory framework/ reimbursement structure
    • 8.4.5.3. Competitive scenario
    • 8.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.6. Norway
    • 8.4.6.1. Key country dynamics
    • 8.4.6.2. Regulatory framework/ reimbursement structure
    • 8.4.6.3. Competitive scenario
    • 8.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.7. Sweden
    • 8.4.7.1. Key country dynamics
    • 8.4.7.2. Regulatory framework/ reimbursement structure
    • 8.4.7.3. Competitive scenario
    • 8.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.8. Denmark
    • 8.4.8.1. Key country dynamics
    • 8.4.8.2. Regulatory framework/ reimbursement structure
    • 8.4.8.3. Competitive scenario
    • 8.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Japan
    • 8.5.1.1. Key country dynamics
    • 8.5.1.2. Regulatory framework/ reimbursement structure
    • 8.5.1.3. Competitive scenario
    • 8.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.2. China
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Regulatory framework/ reimbursement structure
    • 8.5.2.3. Competitive scenario
    • 8.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.3. India
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Regulatory framework/ reimbursement structure
    • 8.5.3.3. Competitive scenario
    • 8.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.4. Australia
    • 8.5.4.1. Key country dynamics
    • 8.5.4.2. Regulatory framework/ reimbursement structure
    • 8.5.4.3. Competitive scenario
    • 8.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.5. South Korea
    • 8.5.5.1. Key country dynamics
    • 8.5.5.2. Regulatory framework/ reimbursement structure
    • 8.5.5.3. Competitive scenario
    • 8.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.6. Thailand
    • 8.5.6.1. Key country dynamics
    • 8.5.6.2. Regulatory framework/ reimbursement structure
    • 8.5.6.3. Competitive scenario
    • 8.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 8.6. Latin America
  • 8.6.1. Brazil
    • 8.6.1.1. Key country dynamics
    • 8.6.1.2. Regulatory framework/ reimbursement structure
    • 8.6.1.3. Competitive scenario
    • 8.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.2. Argentina
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Regulatory framework/ reimbursement structure
    • 8.6.2.3. Competitive scenario
    • 8.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 8.7. MEA
  • 8.7.1. South Africa
    • 8.7.1.1. Key country dynamics
    • 8.7.1.2. Regulatory framework/ reimbursement structure
    • 8.7.1.3. Competitive scenario
    • 8.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.2. Saudi Arabia
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Regulatory framework/ reimbursement structure
    • 8.7.2.3. Competitive scenario
    • 8.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.3. UAE
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Regulatory framework/ reimbursement structure
    • 8.7.3.3. Competitive scenario
    • 8.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.4. Kuwait
    • 8.7.4.1. Key country dynamics
    • 8.7.4.2. Regulatory framework/ reimbursement structure
    • 8.7.4.3. Competitive scenario
    • 8.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Recent Developments & Impact Analysis, By Key Manufacturers
• 9.2. Company/Competition Categorization
• 9.3. Vendor Landscape
  • 9.3.1. List of key distributors and channel partners
  • 9.3.2. Key customers
  • 9.3.3. Key company market share analysis, 2024
• 9.4. Company Profiles
  • 9.4.1. Medtronic plc
    • 9.4.1.1. Company overview
    • 9.4.1.2. Financial performance
    • 9.4.1.3. Product benchmarking
    • 9.4.1.4. Strategic initiatives
  • 9.4.2. Boston Scientific Corporation
    • 9.4.2.1. Company overview
    • 9.4.2.2. Financial performance
    • 9.4.2.3. Product benchmarking
    • 9.4.2.4. Strategic initiatives
  • 9.4.3. Angiodynamics, Inc
    • 9.4.3.1. Company overview
    • 9.4.3.2. Financial performance
    • 9.4.3.3. Product benchmarking
    • 9.4.3.4. Strategic initiatives
  • 9.4.4. Abbott
    • 9.4.4.1. Company overview
    • 9.4.4.2. Financial performance
    • 9.4.4.3. Product benchmarking
    • 9.4.4.4. Strategic initiatives
  • 9.4.5. MicroPort Scientific Corporation
    • 9.4.5.1. Company overview
    • 9.4.5.2. Financial performance
    • 9.4.5.3. Product benchmarking
    • 9.4.5.4. Strategic initiatives
  • 9.4.6. B. BRAUN SE
    • 9.4.6.1. Company overview
    • 9.4.6.2. Financial performance
    • 9.4.6.3. Product benchmarking
    • 9.4.6.4. Strategic initiatives
  • 9.4.7. KONINKLIJKE PHILIPS N.V.
    • 9.4.7.1. Company overview
    • 9.4.7.2. Financial performance
    • 9.4.7.3. Product benchmarking
    • 9.4.7.4. Strategic initiatives
  • 9.4.8. GE Healthcare
    • 9.4.8.1. Company overview
    • 9.4.8.2. Financial performance
    • 9.4.8.3. Product benchmarking
    • 9.4.8.4. Strategic initiatives
  • 9.4.9. Cardinal Health
    • 9.4.9.1. Company overview
    • 9.4.9.2. Financial performance
    • 9.4.9.3. Product benchmarking
    • 9.4.9.4. Strategic initiatives
  • 9.4.10. SIEMENS HEALTHINEERS AG
    • 9.4.10.1. Company overview
    • 9.4.10.2. Financial performance
    • 9.4.10.3. Product benchmarking
    • 9.4.10.4. Strategic initiatives
  • 9.4.11. SHIMADZU CORPORATION
    • 9.4.11.1. Company overview
    • 9.4.11.2. Financial performance
    • 9.4.11.3. Product benchmarking
    • 9.4.11.4. Strategic initiatives

관련자료